Clinical Trials Browser

Phase 2 × Fluorodeoxyglucose F18 × Gynecologic × Clear all

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT00794339 2023-08-14

ACRIN6682

Phase 2 Terminated

73 enrolled 19 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00941070 2017-11-17

Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

Phase 2 Completed

26 enrolled 23 charts

Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT00559377 2016-12-30

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

Phase 2 Completed

16 enrolled 7 charts

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

ACRIN6682

Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer